Clinical Trial Update: LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial named LIVERAGE is evaluating Survodutide for metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Fibrosis
• Metabolic Dysfunction-associated Steatohepatitis

Drugs mentioned

• Survodutide (BI456906)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver Fibrosis | Phase 3 | Status: RECRUITING